vs
Alkermes plc.（ALKS）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Alkermes plc.的季度营收约是Revolve Group, Inc.的1.2倍（$384.5M vs $324.4M），Alkermes plc.净利率更高（12.8% vs 5.7%，领先7.1%），Revolve Group, Inc.同比增速更快（10.4% vs -10.6%），Alkermes plc.自由现金流更多（$170.0M vs $-13.3M），过去两年Revolve Group, Inc.的营收复合增速更高（9.5% vs 4.8%）
Alkermes plc是一家全产业链布局的生物制药企业，专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立，2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并，总部位于都柏林，在马萨诸塞州沃尔瑟姆设有研发中心，俄亥俄州威尔明顿建有生产基地。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
ALKS vs RVLV — 直观对比
营收规模更大
ALKS
是对方的1.2倍
$324.4M
营收增速更快
RVLV
高出21.0%
-10.6%
净利率更高
ALKS
高出7.1%
5.7%
自由现金流更多
ALKS
多$183.3M
$-13.3M
两年增速更快
RVLV
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $384.5M | $324.4M |
| 净利润 | $49.3M | $18.6M |
| 毛利率 | 88.0% | 53.3% |
| 营业利润率 | 15.1% | 6.3% |
| 净利率 | 12.8% | 5.7% |
| 营收同比 | -10.6% | 10.4% |
| 净利润同比 | -66.3% | 50.4% |
| 每股收益（稀释后） | $0.29 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALKSRVLV
| Q4 25 | $384.5M | $324.4M | ||
| Q3 25 | $394.2M | $295.6M | ||
| Q2 25 | $390.7M | $309.0M | ||
| Q1 25 | $306.5M | $296.7M | ||
| Q4 24 | $430.0M | $293.7M | ||
| Q3 24 | $378.1M | $283.1M | ||
| Q2 24 | $399.1M | $282.5M | ||
| Q1 24 | $350.4M | $270.6M |
净利润ALKSRVLV
| Q4 25 | $49.3M | $18.6M | ||
| Q3 25 | $82.8M | $21.2M | ||
| Q2 25 | $87.1M | $10.2M | ||
| Q1 25 | $22.5M | $11.8M | ||
| Q4 24 | $146.5M | $12.3M | ||
| Q3 24 | $92.4M | $11.0M | ||
| Q2 24 | $91.4M | $15.4M | ||
| Q1 24 | $36.8M | $10.9M |
毛利率ALKSRVLV
| Q4 25 | 88.0% | 53.3% | ||
| Q3 25 | 86.9% | 54.6% | ||
| Q2 25 | 87.3% | 54.1% | ||
| Q1 25 | 83.9% | 52.0% | ||
| Q4 24 | 85.6% | 52.5% | ||
| Q3 24 | 83.3% | 51.2% | ||
| Q2 24 | 84.6% | 54.0% | ||
| Q1 24 | 83.3% | 52.3% |
营业利润率ALKSRVLV
| Q4 25 | 15.1% | 6.3% | ||
| Q3 25 | 22.6% | 7.1% | ||
| Q2 25 | 23.8% | 5.8% | ||
| Q1 25 | 4.5% | 5.0% | ||
| Q4 24 | 37.8% | 3.9% | ||
| Q3 24 | 27.7% | 5.0% | ||
| Q2 24 | 27.5% | 5.8% | ||
| Q1 24 | 12.4% | 3.4% |
净利率ALKSRVLV
| Q4 25 | 12.8% | 5.7% | ||
| Q3 25 | 21.0% | 7.2% | ||
| Q2 25 | 22.3% | 3.3% | ||
| Q1 25 | 7.3% | 4.0% | ||
| Q4 24 | 34.1% | 4.2% | ||
| Q3 24 | 24.4% | 3.9% | ||
| Q2 24 | 22.9% | 5.4% | ||
| Q1 24 | 10.5% | 4.0% |
每股收益（稀释后）ALKSRVLV
| Q4 25 | $0.29 | $0.27 | ||
| Q3 25 | $0.49 | $0.29 | ||
| Q2 25 | $0.52 | $0.14 | ||
| Q1 25 | $0.13 | $0.16 | ||
| Q4 24 | $0.88 | $0.18 | ||
| Q3 24 | $0.55 | $0.15 | ||
| Q2 24 | $0.53 | $0.21 | ||
| Q1 24 | $0.21 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $292.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.8B | $512.5M |
| 总资产 | $2.5B | $765.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALKSRVLV
| Q4 25 | $388.6M | $292.3M | ||
| Q3 25 | $616.4M | $315.4M | ||
| Q2 25 | $521.2M | $310.7M | ||
| Q1 25 | $399.8M | $300.8M | ||
| Q4 24 | $291.1M | $256.6M | ||
| Q3 24 | $396.3M | $252.8M | ||
| Q2 24 | $535.1M | $244.7M | ||
| Q1 24 | $420.8M | $273.4M |
股东权益ALKSRVLV
| Q4 25 | $1.8B | $512.5M | ||
| Q3 25 | $1.7B | $490.2M | ||
| Q2 25 | $1.6B | $468.6M | ||
| Q1 25 | $1.5B | $453.4M | ||
| Q4 24 | $1.5B | $437.8M | ||
| Q3 24 | $1.3B | $420.8M | ||
| Q2 24 | $1.3B | $405.8M | ||
| Q1 24 | $1.3B | $389.9M |
总资产ALKSRVLV
| Q4 25 | $2.5B | $765.0M | ||
| Q3 25 | $2.3B | $751.3M | ||
| Q2 25 | $2.3B | $722.9M | ||
| Q1 25 | $2.1B | $713.9M | ||
| Q4 24 | $2.1B | $665.5M | ||
| Q3 24 | $2.2B | $670.9M | ||
| Q2 24 | $2.2B | $657.8M | ||
| Q1 24 | $2.1B | $650.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.1M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | $-13.3M |
| 自由现金流率自由现金流/营收 | 44.2% | -4.1% |
| 资本支出强度资本支出/营收 | 0.0% | 1.0% |
| 现金转化率经营现金流/净利润 | 3.45× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $480.3M | $48.0M |
8季度趋势，按日历期对齐
经营现金流ALKSRVLV
| Q4 25 | $170.1M | $-10.2M | ||
| Q3 25 | $101.7M | $11.8M | ||
| Q2 25 | $150.2M | $12.6M | ||
| Q1 25 | $98.8M | $45.1M | ||
| Q4 24 | $190.4M | $3.9M | ||
| Q3 24 | $81.6M | $9.1M | ||
| Q2 24 | $146.0M | $-24.7M | ||
| Q1 24 | $21.1M | $38.4M |
自由现金流ALKSRVLV
| Q4 25 | $170.0M | $-13.3M | ||
| Q3 25 | $84.4M | $7.5M | ||
| Q2 25 | $137.2M | $10.4M | ||
| Q1 25 | $88.7M | $43.4M | ||
| Q4 24 | $180.6M | $2.1M | ||
| Q3 24 | $73.3M | $8.0M | ||
| Q2 24 | $138.9M | $-25.7M | ||
| Q1 24 | $12.8M | $36.7M |
自由现金流率ALKSRVLV
| Q4 25 | 44.2% | -4.1% | ||
| Q3 25 | 21.4% | 2.5% | ||
| Q2 25 | 35.1% | 3.4% | ||
| Q1 25 | 28.9% | 14.6% | ||
| Q4 24 | 42.0% | 0.7% | ||
| Q3 24 | 19.4% | 2.8% | ||
| Q2 24 | 34.8% | -9.1% | ||
| Q1 24 | 3.6% | 13.5% |
资本支出强度ALKSRVLV
| Q4 25 | 0.0% | 1.0% | ||
| Q3 25 | 4.4% | 1.5% | ||
| Q2 25 | 3.3% | 0.7% | ||
| Q1 25 | 3.3% | 0.6% | ||
| Q4 24 | 2.3% | 0.6% | ||
| Q3 24 | 2.2% | 0.4% | ||
| Q2 24 | 1.8% | 0.4% | ||
| Q1 24 | 2.4% | 0.6% |
现金转化率ALKSRVLV
| Q4 25 | 3.45× | -0.55× | ||
| Q3 25 | 1.23× | 0.56× | ||
| Q2 25 | 1.72× | 1.24× | ||
| Q1 25 | 4.40× | 3.82× | ||
| Q4 24 | 1.30× | 0.32× | ||
| Q3 24 | 0.88× | 0.83× | ||
| Q2 24 | 1.60× | -1.60× | ||
| Q1 24 | 0.57× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
